Mitchell L. Krassan
2018
In 2018, Mitchell L. Krassan earned a total compensation of $1.1M as Chief Strategy Performance Officer at TherapeuticsMD, a 8% decrease compared to previous year.
Compensation breakdown
| Bonus | $45,000 |
|---|---|
| Non-Equity Incentive Plan | $180,000 |
| Option Awards | $523,993 |
| Salary | $360,000 |
| Other | $20,359 |
| Total | $1,129,352 |
Krassan received $524K in option awards, accounting for 46% of the total pay in 2018.
Krassan also received $45K in bonus, $180K in non-equity incentive plan, $360K in salary and $20.4K in other compensation.
Rankings
In 2018, Mitchell L. Krassan's compensation ranked 8,595th out of 14,244 executives tracked by ExecPay. In other words, Krassan earned more than 39.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,595 out of 14,244 | 40th |
Division Manufacturing | 3,423 out of 5,765 | 41st |
Major group Chemicals And Allied Products | 1,292 out of 2,128 | 39th |
Industry group Drugs | 1,079 out of 1,817 | 41st |
Industry Pharmaceutical Preparations | 841 out of 1,391 | 40th |
Source: SEC filing on April 29, 2019.
Krassan's colleagues
We found four more compensation records of executives who worked with Mitchell L. Krassan at TherapeuticsMD in 2018.